Reuters logo
BRIEF-Argenx to partner with Broteio Pharma to develop therapeutic antibody
March 21, 2017 / 6:13 AM / 6 months ago

BRIEF-Argenx to partner with Broteio Pharma to develop therapeutic antibody

March 21 (Reuters) - ArGEN X BV:

* Announces collaboration with Broteio Pharma to develop therapeutic antibody for severe autoimmune diseases

* Differentiated antibody to address complement target

* Represents latest collaboration to stem from Co’s innovative access program

* Granted option to license program after preclinical proof-of-concept

* Co and Broteio will jointly develop complement-targeted antibody to establish preclinical proof-of-concept using argenx’s proprietary suite of technologies Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below